1 Bray F,Laversanne M,Sung H,et al.Global cancer statistics 2022:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2024,74(3):229-263. 2 顾娜,谭珵,王璐瑶,等.美登木素对人甲状腺癌细胞增殖、侵袭、迁移、凋亡和自噬的影响[J].实用肿瘤学杂志,2025,39(1):21-29. 3 Lan H,Lin C,Yuan H.Knockdown of KRAB domain-associated protein 1 suppresses the proliferation,migration and invasion of thyroid cancer cells by regulating P68/DEAD box protein 5[J].Bioengineered,2022,13(5):11945-11957. 4 陈诗颖,崔岱.未分化甲状腺癌新型分子靶向与免疫治疗的研究进展[J].国际内分泌代谢杂志,2023,43(2):96-99. 5 Son J,Lee SY.Therapeutic potential of ursonic acid:comparison with ursolic acid[J].Biomolecules,2020,10(11):1505. 6 杨俊,梁玉清,黄蕊,等.熊果酸拼接抗肿瘤活性分子衍生物的合成及抗肺癌活性研究[J].化学研究与应用,2024,36(10):2273-2283. 7 石尧,汪晴,张骏鸿,等.熊果酸对人结直肠癌SW620细胞恶性生物学行为的影响及机制[J].中国药房,2024,35(18):2252-2257. 8 Kim GD.Ursolic acid decreases the proliferation of MCF-7 cell-derived breast cancer stem-like cells by modulating the ERK and PI3K/Akt signaling pathways[J].Prev Nutr Food Sci,2021,26(4):434-444. 9 Lee KC,Chen YL,Lin PY,et al.Ursolic acid-induced apoptosis via regulation of the PI3K/Akt and MAPK signaling pathways in Huh-7 cells[J].Molecules,2018,23(8):2016. 10 Zhao H,Tang S,Tao Q,et al.Ursolic acid suppresses colorectal cancer by down-regulation of Wnt/β-Catenin signaling pathway activity[J].J Agric Food Chem,2023,71(9):3981-3993. 11 Song GR,Choi YJ,Park SJ,et al.Root bark of morus alba l.and its bioactive ingredient,ursolic acid,suppress the proliferation of multiple myeloma cells by inhibiting Wnt/β-Catenin pathway[J].J Microbiol Biotechnol,2021,31(11):1559-1567. 12 Zhang ZJ,Xiao Q,Li XY.MicroRNA-574-5p directly targets FOXN3 to mediate thyroid cancer progression via Wnt/β-catenin signaling pathway[J].Pathol Res Pract,2020,216(6):152939. 13 Zhang W,Ruan X,Li Y,et al.KDM1A promotes thyroid cancer progression and maintains stemness through the Wnt/β-catenin signaling pathway[J].Theranostics,2022,12(4):1500-1517. 14 Wen HL,Xu ZM,Lin SY,et al.miR-597-3p inhibits invasion and migration of thyroid carcinoma SW579 cells by targeting RAB23[J].Endokrynol Pol,2021,72(1):22-28. 15 Filetti S,Durante C,Hartl D,et al.Thyroid cancer:ESMO Clinical Practice Guidelines for diagnosis,treatment and follow-up[J].Ann Oncol,2019,30(12):1856-1883. 16 Langdon J,Gupta A,Sharbidre K,et al.Thyroid cancer in pregnancy:diagnosis,management,and treatment[J].Abdom Radiol(NY),2023,48(5):1724-1739. 17 高晓洁,季梅丽,张乐乐,等.不同剂量131I对分化型甲状腺癌患者摄碘率、甲状腺激素水平及生活质量的影响[J].现代生物医学进展,2023,23(2):273-276,282. 18 Cabanillas ME,Ryder M,Jimenez C.Targeted therapy for advanced thyroid cancer:kinase inhibitors and beyond[J].Endocr Rev,2019,40(6):1573-1604. 19 Boucai L,Zafereo M,Cabanillas ME.Thyroid cancer:a review[J].JAMA,2024,331(5):425-435. 20 Khwaza V,Oyedeji OO,Aderibigbe BA.Ursolic acid-based derivatives as potential anti-cancer agents:an update[J].Int J Mol Sci,2020,21(16):5920. 21 陶秋,王敏敏,雷家荣,等.基于Wnt信号通路的熊果酸调节结直肠癌SW480细胞自噬的研究[J].中药药理与临床,2024,40(11):41-47. 22 谭福雄.基于P53/Bcl-2/CASP3信号通路研究熊果酸治疗肝细胞肝癌的作用机制[D].陕西中医药大学,2021. 23 Luo F,Zhao J,Liu S,et al.Ursolic acid augments the chemosensitivity of drug-resistant breast cancer cells to doxorubicin by AMPK-mediated mitochondrial dysfunction[J].Biochem Pharmacol,2022,205(15):115278. 24 Zhang X,Li T,Gong ES,et al.Antiproliferative activity of ursolic acid in MDA-MB-231 human breast cancer cells through Nrf2 pathway regulation[J].J Agric Food Chem,2020,68(28):7404-7415. 25 Liu J,Xiao Q,Xiao J,et al.Wnt/β-catenin signalling:function,biological mechanisms,and therapeutic opportunities[J].Signal Transduct Target Ther,2022,7(1):3. 26 郑艳,张茜,孙菲.敲低S100A1通过降低WNT/β-catenin信号活性抑制甲状腺癌SW579细胞增殖[J].临床输血与检验,2021,23(2):146-152. 27 Lin CM,Chen HH,Lin CA,et al.Apigenin-induced lysosomal degradation of β-catenin in Wnt/β-catenin signaling[J].Sci Rep,2017,7(1):372. 28 Wang B,Zhou Y,Zhang P,et al.Solasonine inhibits cancer stemness and metastasis by modulating glucose metabolism via Wnt/β-Catenin/Snail pathway in osteosarcoma[J].Am J Chin Med,2023,51(5):1293-1308. |